Bevespi Aerosphere is the first product approved using AZ's Co-Suspension Technology. This technology enables consistent delivery of one or more different medicines from a single pMDI.

AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive ...